References
- KamachiSMotojimaHOhedaMProperties of natural granulocyte colony-stimulating factor (G-CSF)Kiso to Rinsho Clinical Report199125311316
- ShochatERom-KedarVSegelLAG-CSF control of neutrophils dynamics in the bloodBull Math Biol2007692299233817554586
- FrankTSchlachetzkiJCGörickeBBoth systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomyBMC Neurosci2009104919442279
- McCollumMMaZCohenEPost-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson’s diseaseMol Neurobiol20104141041920405343
- PitzerCKlussmannSKrügerCThe hematopoietic factor granulocyte- colony stimulating factor improves outcome in experimental spinal cord injuryJ Neurochem201011393094220202082
- SchlagerGWGriesmaierEWegleiterKSystemic G-CSF treatment does not improve long-term outcomes after neonatal hypoxic-ischaemic brain injuryExp Neurol2011230677421145889
- BartoliniAViglianiM-CMagrassiLVercelliARossiFG-CSF administration to adult mice stimulates the proliferation of microglia but does not modify the outcome of ischemic injuryNeurobiol Dis20114164064921111821
- LieschkeGJRamenghiUO’ConnorMPSheridanWSzerJMorstynGStudies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantationBr J Haematol1992825895951283080
- KikkawaMMatsubaraSTakatokuMGranulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropeniaJ Obstet Gynaecol Res20083428629018412800
- KantarjianHMEsteyEO’BrienSGranulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remissionCancer199372295029557693325
- FeliciACarliniPRuggeriEMBi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus G-CSF in advanced gastric cancer: A multicentric phase II studyCancer Chemother Pharmacol200657596416001173
- RussellHShoheJMPediatric oncology: G-CSF counteracts chemotherapy toxicity in neuroblastomaNat Rev Clin Oncol201186821102531
- CreaFGiovannettiEZinzaniPLDanesiRPharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimizationCrit Rev Oncol Hematol200972214419111474
- MachidaMSanoKArakawaMHayashiMAwazuSAbsorption of recombinant human granulocyte colony- stimulating factor (rhG-CSF) from rat nasal mucosaPharm Res199310137213777694272
- NomuraHAkamisakaSMaruyamaKEffects of a dosing solution on the nasal absorption of non-glycosylated recombinant human granulocyte colony-stimulating factor in ratsBiol Pharm Bull199619149014938951170
- WatanabeYKikuchiRKiriyamaMIncrease in total blood leukocyte count following intranasal administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rabbits with cyclophosphamide-induced leucopeniaBiol Pharm Bull199518108410888535401
- MachidaMHayashiMAwazuSThe effects of absorption enhancers on the pulmonary absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in ratsBiol Pharm Bull200023848610706417
- MachidaMHayashiMAwazuSPulmonary absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after intratracheal administration to ratsBiol Pharm Bull1996192592628850318
- NivenRWWhitcombKLShanerLIpAYKinstlerOBThe pulmonary absorption of aerosolized intratracheally instilled rhG-CSF and monoP-EGylated rhG-CSFPharm Res199512134313498570533
- EiamtrakarnSItohYKishimotoJGastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model proteinBiomaterials20022314515211762832
- TakayaTIkedaCImagawaNNiwaKTakadaKDevelopment of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony stimulating factor (rhG-CSF) in beagle dogsJ Pharm Pharmacol1995474744787545751
- Jensen-PippoKEWhitcombKLDePrinceRBRalphLHabberfieldADEnteral bioavailability of human granulocyte colony-stimulating factor conjugated with poly(ethyleneglycol)Pharm Res1996131021078668656
- ShenWCOral peptide and protein delivery: unfulfilled promisesDrug Discov Today2003860760812867138
- LeeHJProtein drug oral delivery: the recent progressArch Pharm Res20022557258412433186
- ChoiSHLeeHParkTGPEGylation of G-CSF using cleavable oligolactic acid linkageJ Control Release20038927128412711450
- HalpernWRiccobeneTAAgostiniHAlbugranin, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeysPharm Res2002191720172912458679
- TanakaHSatake-IshikawaRIshikawaMMatsukiSAsanoKPharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in ratsCancer Res199151371037141712246
- ChoiSHParkTGG-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion methodInt J Pharm200631122322816423477
- MaedaHNakagawaTAdachiNDesign of long-acting formulation of protein drugs with a double-layer structure and its application to rhG-CSFJ Control Release20039128129712932708
- GibaudSRousseauCWeingartenCPolyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF)J Control Release1998521311399685943
- JinTZhuJWuFYuanWGengLLZhuHPreparing polymer- based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagentsJ Control Release2008128505918417240
- YuanWGengYWuFPreparation of polysaccharide glassy nanoparticles with stabilization of proteinsInt J Pharm200936615415918835346
- YuanWWuFGengYXuSJinTPreparation of dextran glassy particles through freezing-induced phase separationInt J Pharm2007339768317391880
- YuanWWuFGuoMJinTDevelopment of protein delivery microsphere system by a novel s/o/o/w multi-emulsionEur J Pharm Sci20093621221818832030
- RenTYuanWZhaoHJinTSustained-release polylactide-co-glycolide microspheres loaded with pre-formulated protein polysaccharide nanoparticlesMicro Nano Lett201167074
- GengYYuanWWuFChenJHeMJinTFormulating erythropoietin- loaded sustained-release PLGA microspheres without protein aggregationJ Control Release200813025926518620011
- ShirafujiNAsanoSMatsudaSWatariKTakakuFNagataSA new bioassay for human granulocyte colony stimulating factor (G-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its level in sera from normal healthy persons and patients with infections and hematological disordersExp Hematol1989171161192463930
- BöyumAIsolation of mononuclear cells and granulocytes from human bloodScand J Clin Lab Invest Suppl1968217789
- XuLWuFYuanWJinTControlled-release implant system formulated using biodegradable hemostatic gauze as scaffoldInt J Pharm200835524925818249510
- ClelandJLJonesJSStable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheresPharm Res199613146414758899836
- SchwendemanSPRecent advances in the stabilization of protein encapsulated in injectable PLGA delivery systemsCrit Rev Ther Drug Carrier Syst200219739812046892
- YuanWZhangYWuFPreparation of protein-loaded sustained-release microspheres via ‘solid-in-oil-in-hydrophilic oil-in-ethanol (S/O/hO/E)’ emulsificationColloids Surf B Biointerfaces20107932633320483570
- RicciMSSarkarCAFallonEMLauffenburgerDABremsDNpH dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factorProtein Sci2003121030103812717025
- WischkeCSchwendemanSPPrinciples of encapsulating hydrophobic drugs in PLA/PLGA microparticlesInt J Pharm200836429832718621492
- KimTHParkTGCritical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheresInt J Pharm200427120721415129987
- HuZLiuYYuanWWuFSuJJinTEffect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheresColloids Surf B Biointerfaces20118620621121524893